BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32891325)

  • 1. Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease.
    Han JY; Ahn KS; Baek WK; Suh SI; Kim YH; Kim TS; Kang KJ
    Surg Oncol; 2020 Sep; 34():174-181. PubMed ID: 32891325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
    Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
    World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
    Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
    Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual causes of benign biliary strictures with cholangiographic features of cholangiocarcinoma.
    Binkley CE; Eckhauser FE; Colletti LM
    J Gastrointest Surg; 2002; 6(5):676-81. PubMed ID: 12399056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
    Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
    Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
    Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Liu X; Sanaka MR; Jang S; Vargo JJ; Parsi MA
    Dig Dis Sci; 2013 Oct; 58(10):2986-92. PubMed ID: 23828141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
    Chen CY; Lin XZ; Tsao HC; Shiesh SC
    Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocentric study of bile aspiration associated with biliary brushing performed during endoscopic retrograde cholangiopancreatography in 239 patients with symptomatic biliary stricture.
    Fior-Gozlan M; Giovannini D; Rabeyrin M; Mc Leer-Florin A; Laverrière MH; Bichard P
    Cancer Cytopathol; 2016 May; 124(5):330-9. PubMed ID: 26700399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Wiggers JK; Ruys AT; Groot Koerkamp B; Beuers U; ten Kate FJ; van Gulik TM
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1582-94. PubMed ID: 24787096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
    Li L; Masica D; Ishida M; Tomuleasa C; Umegaki S; Kalloo AN; Georgiades C; Singh VK; Khashab M; Amateau S; Li Z; Okolo P; Lennon AM; Saxena P; Geschwind JF; Schlachter T; Hong K; Pawlik TM; Canto M; Law J; Sharaiha R; Weiss CR; Thuluvath P; Goggins M; Shin EJ; Peng H; Kumbhari V; Hutfless S; Zhou L; Mezey E; Meltzer SJ; Karchin R; Selaru FM
    Hepatology; 2014 Sep; 60(3):896-907. PubMed ID: 24497320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study.
    Navaneethan U; Parsi MA; Lourdusamy D; Grove D; Sanaka MR; Hammel JP; Vargo JJ; Dweik RA
    Dig Dis Sci; 2015 Jul; 60(7):2150-7. PubMed ID: 25708900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
    Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A
    Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
    Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
    J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful cytologic diagnosis of cholangiocarcinoma from within a recently placed biliary Wallstent.
    Baron TH; Morgan DE
    Gastrointest Endosc; 1997 Sep; 46(3):288-9. PubMed ID: 9378229
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholangiocarcinoma: principles and current trends.
    Zografos GN; Farfaras A; Zagouri F; Chrysikos D; Karaliotas K
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):10-20. PubMed ID: 21269929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.
    Muraki R; Morita Y; Ida S; Kitajima R; Furuhashi S; Takeda M; Kikuchi H; Hiramatsu Y; Takanashi Y; Hamaya Y; Sugimoto K; Ito J; Kawata K; Kawasaki H; Sato T; Kahyo T; Setou M; Takeuchi H
    Cancer Med; 2023 Jun; 12(12):13007-13018. PubMed ID: 37096775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy.
    Sakamoto E; Hayakawa N; Kamiya J; Kondo S; Nagino M; Kanai M; Miyachi M; Uesaka K; Nimura Y
    World J Surg; 1999 Oct; 23(10):1038-43; discussion 1043-4. PubMed ID: 10512944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.